Market Overview:
The global artificial tears ointment market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing prevalence of dry eye syndrome (DES) and rising awareness about the benefits of artificial tears ointment. Based on type, the global artificial tears ointment market is segmented into human artificial tear ointment and animal artificial tear ointment. The human artificial tear ointment segment is expected to account for a larger share of the global market in 2018. This can be attributed to factors such as increasing incidence of DES and growing demand for over-the-counter products. However, the animal artificial tear ointment segment is projected to grow at a higher CAGR during the forecast period owing to rising demand from pet owners for products that can improve their pet's vision quality. Based on application, hospitals are estimated to account for a larger share of the global Artificial Tears Ophthalmic OINTMENT Market in 2018; however, clinics are projected grow at a higher CAGR duringthe forecast period owingto growing demand from consumersfor convenient and affordable healthcare services . Other applications include retail pharmaciesand online stores .
Product Definition:
artificial tears ointment: a medication used to lubricate the eyes.
Artificial Tear Ointment for Humans:
Artificial tear ointment is used to treat dry eye disease, it's also used as a skin preparation before surgery. It helps in lubricating the eyes and reduces inflammation & swelling. The major factor that propels the growth of this market is increasing prevalence of various eye diseases such as dry eye, cataract, glaucoma and others. Moreover growing R&D activities by many companies for developing new products with better efficiency propels the market growth further.
Artificial Tear Ointment for Animals:
Artificial tear ointment is a topical skin preparation used to treat dry eye, corneal ulcers, and other external conditions. It helps in lubricating the eyes and provides temporary relief from itchy, painful eyes. The product also reduces inflammation of the conjunctiva surface by neutralizing bacterial toxins present there.
Application Insights:
The others application segment held the largest share of more than 70.0% in 2017. The other applications include veterinary clinics, zoos and gardens, and research laboratories among others. Artificial tear ointments are widely used in hospitals due to their fast-acting properties that help reduce redness, itching, and pain caused by eye irritation or dryness as well as to quickly restore the natural moisture of the eye surface. In addition, these products can be used for a variety of other indications such as corneal ulcers or keratoconus among others that require frequent medical attention at a hospital level across various regions globally owing to their easy availability over-the-counter (OTC).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of dry eye disease, rising awareness about artificial tears and increased availability of products in this region. The U.S., which is the largest pharmaceutical market, accounted for a major share owing to high R&D investments by leading companies and an increase in healthcare expenditure by government agencies.
Asia Pacific is expected to witness lucrative growth over the forecast period as key players are introducing new products with advanced technologies at affordable prices catering to unmet medical needs especially in developing countries such as India and China. Moreover, growing demand for ophthalmic solutions due to rapidly aging population will drive growth during the forecast period from 2018-2030 In addition, low cost of clinical trials conducted on animals compared with that conducted on humans has encouraged many pharmaceutical companies operating globally including Pfizer Inc.; Merck & Co., Inc.
Growth Factors:
- Increasing prevalence of dry eye syndrome: The increasing prevalence of dry eye syndrome is one of the key growth drivers for the artificial tears ointment market. According to a study by The National Eye Institute, it is estimated that around 14%–18% Americans suffer from dry eye syndrome. This number is expected to increase in the coming years due to the growing aging population and rising awareness about the condition.
- Rising demand for minimally invasive procedures: The demand for minimally invasive procedures is increasing due to their advantages such as shorter recovery time, less pain, and lower risk of complications as compared to traditional surgery. This is driving the growth of the artificial tears ointment market as these products are used in minimally invasive procedures such as laser-assisted cataract surgery and refractive surgery.
- Growing popularity of LASIK surgeries: LASIK (laser-assisted in situ keratomileusis) surgeries are becoming increasingly popular due to their high success rates and short recovery times. As a result, there has been a surge in demand for products that are used during these surgeries, including artificial tears ointments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Tears Ointment Market Research Report
By Type
Artificial Tear Ointment for Humans, Artificial Tear Ointment for Animals
By Application
Hospital, Clinic, Others
By Companies
Allergan, Alcon, Bausch & Lomb, Ocusoft, Nicox, Ursapharm, Medicom Healthcare, OptixCare, Thera Tears, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Tears Ointment Market Report Segments:
The global Artificial Tears Ointment market is segmented on the basis of:
Types
Artificial Tear Ointment for Humans, Artificial Tear Ointment for Animals
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Alcon
- Bausch & Lomb
- Ocusoft
- Nicox
- Ursapharm
- Medicom Healthcare
- OptixCare
- Thera Tears
- Allergan
Highlights of The Artificial Tears Ointment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Tear Ointment for Humans
- Artificial Tear Ointment for Animals
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Tears Ointment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial Tears Ointment is a medication used to moisten the eyes.
Some of the major players in the artificial tears ointment market are Allergan, Alcon, Bausch & Lomb, Ocusoft, Nicox, Ursapharm, Medicom Healthcare, OptixCare, Thera Tears, Allergan.
The artificial tears ointment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Tears Ointment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Artificial Tears Ointment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Artificial Tears Ointment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Artificial Tears Ointment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Artificial Tears Ointment Market Size & Forecast, 2018-2028
4.5.1 Artificial Tears Ointment Market Size and Y-o-Y Growth
4.5.2 Artificial Tears Ointment Market Absolute $ Opportunity
Chapter 5 Global Artificial Tears Ointment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Artificial Tears Ointment Market Size Forecast by Type
5.2.1 Artificial Tear Ointment for Humans
5.2.2 Artificial Tear Ointment for Animals
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Artificial Tears Ointment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Artificial Tears Ointment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Tears Ointment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Tears Ointment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Artificial Tears Ointment Analysis and Forecast
9.1 Introduction
9.2 North America Artificial Tears Ointment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Artificial Tears Ointment Market Size Forecast by Type
9.6.1 Artificial Tear Ointment for Humans
9.6.2 Artificial Tear Ointment for Animals
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Artificial Tears Ointment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Artificial Tears Ointment Analysis and Forecast
10.1 Introduction
10.2 Europe Artificial Tears Ointment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Artificial Tears Ointment Market Size Forecast by Type
10.6.1 Artificial Tear Ointment for Humans
10.6.2 Artificial Tear Ointment for Animals
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Artificial Tears Ointment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Artificial Tears Ointment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Artificial Tears Ointment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Artificial Tears Ointment Market Size Forecast by Type
11.6.1 Artificial Tear Ointment for Humans
11.6.2 Artificial Tear Ointment for Animals
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Artificial Tears Ointment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Artificial Tears Ointment Analysis and Forecast
12.1 Introduction
12.2 Latin America Artificial Tears Ointment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Artificial Tears Ointment Market Size Forecast by Type
12.6.1 Artificial Tear Ointment for Humans
12.6.2 Artificial Tear Ointment for Animals
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Artificial Tears Ointment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Artificial Tears Ointment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Artificial Tears Ointment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Artificial Tears Ointment Market Size Forecast by Type
13.6.1 Artificial Tear Ointment for Humans
13.6.2 Artificial Tear Ointment for Animals
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Artificial Tears Ointment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Tears Ointment Market: Competitive Dashboard
14.2 Global Artificial Tears Ointment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Alcon
14.3.3 Bausch & Lomb
14.3.4 Ocusoft
14.3.5 Nicox
14.3.6 Ursapharm
14.3.7 Medicom Healthcare
14.3.8 OptixCare
14.3.9 Thera Tears
14.3.10 Allergan
